The global vascular grafts market size was USD 5.68 billion in 2023, estimated at USD 5.98 billion in 2024 and is anticipated to reach around USD 9.88 billion by 2034, expanding at a CAGR of 5% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Vascular Grafts Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Vascular Grafts Market, by Product Type, 2024-2034
8.1.1. Vascular Grafts for Aorta Disease
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Peripheral Vascular Grafts
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Endovascular Stent Grafts
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Coronary Artery By-Pass Grafts
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. Vascular Grafts Market, by End Use, 2024-2034
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Vascular Grafts Market, by Application Type, 2024-2034
10.1.1. Cardiac Aneurysm
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Kidney Failure
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Vascular Occlusion
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Coronary Artery Disease
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. Vascular Grafts Market, by Raw Material Type, 2024-2034
11.1.1. Polyester Vascular Grafts
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Polytetrafluoroethylene Vascular Grafts
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Polyurethane Vascular Grafts
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Biological Material Based Vascular Grafts
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Human Saphenous and Umbilical Veins
11.1.5.1. Market Revenue and Forecast (2021-2034)
11.1.6. Tissue Engineered Materials
11.1.6.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.2. Market Revenue and Forecast, by End Use (2021-2034)
12.1.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.1.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.5.2. Market Revenue and Forecast, by End Use (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.6.2. Market Revenue and Forecast, by End Use (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.2. Market Revenue and Forecast, by End Use (2021-2034)
12.2.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.2.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.5.2. Market Revenue and Forecast, by End Use (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.6.2. Market Revenue and Forecast, by End Use (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.7.2. Market Revenue and Forecast, by End Use (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.8.2. Market Revenue and Forecast, by End Use (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.2. Market Revenue and Forecast, by End Use (2021-2034)
12.3.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.3.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.5.2. Market Revenue and Forecast, by End Use (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.6.2. Market Revenue and Forecast, by End Use (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.7.2. Market Revenue and Forecast, by End Use (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.8.2. Market Revenue and Forecast, by End Use (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.2. Market Revenue and Forecast, by End Use (2021-2034)
12.4.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.4.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.5.2. Market Revenue and Forecast, by End Use (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.6.2. Market Revenue and Forecast, by End Use (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.7.2. Market Revenue and Forecast, by End Use (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.8.2. Market Revenue and Forecast, by End Use (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.2. Market Revenue and Forecast, by End Use (2021-2034)
12.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.5.2. Market Revenue and Forecast, by End Use (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.6.2. Market Revenue and Forecast, by End Use (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)
13.1. Getinge AB
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Medtronic PLC
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. LeMaitre vascular Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. WL gore and associates
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. terumo corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Shanghai suokang medical implants Co limited
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Cook Medical
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client